These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7848795)

  • 1. Structural changes in hypertension, the potential for their prevention, arrest and reversal: a focus on felodipine.
    Purcell H; Coats A
    Br J Clin Pract; 1994; 48(6):311-6. PubMed ID: 7848795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of antihypertensive treatment on target organs].
    Fregoso Padilla J
    Arch Cardiol Mex; 2002; 72 Suppl 1():S58-63. PubMed ID: 12001872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The organ damage in arterial hypertension].
    Agabiti-Rosei E; Muiesan ML
    Ann Ital Med Int; 1995 Oct; 10 Suppl():99S-107S. PubMed ID: 8562278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The primary and secondary prevention of hypertensive cardiopathy].
    Agabiti-Rosei E; Muiesan ML
    Ital Heart J; 2000 Jun; 1 Suppl 2():59-66. PubMed ID: 10905130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of dietary salts on the cardiovascular effects of low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.
    Mervaala EM; Malmberg L; Teräväinen TL; Laakso J; Vapaatalo H; Karppanen H
    Br J Pharmacol; 1998 Jan; 123(2):195-204. PubMed ID: 9489606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of a low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.
    Mervaala EM; Teräväinen TL; Malmberg L; Laakso J; Vapaatalo H; Karppanen H
    Br J Pharmacol; 1997 Jun; 121(3):503-10. PubMed ID: 9179393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antihypertensive treatment and left ventricular hypertrophy].
    Agabiti-Rosei E; Muiesan ML; Rizzoni D
    Ann Ital Med Int; 1993 Oct; 8 Suppl():97S-103S. PubMed ID: 8117529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antihypertensive treatment on small artery remodelling.
    Agabiti-Rosei E; Heagerty AM; Rizzoni D
    J Hypertens; 2009 Jun; 27(6):1107-14. PubMed ID: 19293726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regression of left ventricular hypertrophy in hypertensive patients].
    Bosa Ojeda F; García González M; Domínguez Rodríguez A; Barragán Acea A; Miralles Ibarra JM; Lacalzada Almeida J; de Armas Trujillo D
    Rev Esp Cardiol; 1997; 50 Suppl 4():74-6. PubMed ID: 9411592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential therapy with calcium antagonists].
    Scholze JE
    Herz; 2003 Dec; 28(8):754-63. PubMed ID: 14689111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular and microvascular hypertrophy in essential hypertension: clinical relevance and prognostic implications.
    Thürmann PA
    Int J Clin Pharmacol Ther; 1997 May; 35(5):181-7. PubMed ID: 9174872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
    Leenen FH; Myers MG; Joyner CD; Toal CB
    Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Left ventricular remodeling in arterial hypertension and its therapy].
    Dúbrava J
    Vnitr Lek; 1998 Jan; 44(1):50-6. PubMed ID: 9750485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing hypertension-associated cardiorenal risk: the role of heart rate, left ventricular hypertrophy regression, and renoprotection.
    Materson BJ
    Am J Hypertens; 1999 Jan; 12(1 Pt 2):1S-2S. PubMed ID: 10077412
    [No Abstract]   [Full Text] [Related]  

  • 20. Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study.
    Gohlke P; Linz W; Schölkens B; Van Even P; Martorana P; Unger T
    Br J Clin Pract Suppl; 1996 Jul; 84():1-10. PubMed ID: 8994995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.